We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
AbbVie Inc | NYSE:ABBV | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
2.98 | 1.85% | 163.79 | 164.25 | 160.74 | 161.85 | 5,850,104 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM SD
SPECIALIZED DISCLOSURE REPORT
AbbVie Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-35565 |
|
32-0375147 |
(State or other Jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
of Incorporation) |
|
|
|
Identification No.) |
1 North Waukegan Road
North Chicago, Illinois 60064-6400
(Address of principal executive offices)(Zip Code)
Robert A. Michael (847) 932-7900
(Name and telephone number, including area code, of the person to contact in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
x Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2018.
SECTION 1 CONFLICT MINERALS DISCLOSURE
Item 1.01. Conflict Minerals Disclosure and Report
The Conflict Minerals Report for AbbVie Inc. (AbbVie) for the year ended December 31, 2018 is attached as Exhibit 1.01 to this Report and is available on AbbVies website at www.abbvieinvestor.com .
Item 1.02. Exhibit
AbbVies Conflict Minerals Report is attached as Exhibit 1.01 to this Report.
SECTION 2 EXHIBITS
Item 2.01. Exhibits
Exhibit No. |
|
Description |
Exhibit 1.01 |
|
Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
AbbVie Inc. |
|
|
|
(Registrant) |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Robert A. Michael |
|
Date: May 31, 2019 |
|
Robert A. Michael |
|
|
|
Senior Vice President, Chief Financial Officer |
|
|
1 Year AbbVie Chart |
1 Month AbbVie Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions